Can Ireland's clinical genetics services crisis be turned into an opportunity? It's possible, and might be the best way of investing Irish health care €€
Just bumping up the number of clinical genetics consultants, while valuable, is probably not the sustainable solution 1/ https://twitter.com/keelinodonoghue/status/1328378214717288448
Just bumping up the number of clinical genetics consultants, while valuable, is probably not the sustainable solution 1/ https://twitter.com/keelinodonoghue/status/1328378214717288448
2/ It's safe to say that clinical genetics is changing rapidly, and that models of clinical genetics delivery are extremely variable worldwide. Nice overview here: https://www.frontiersin.org/articles/10.3389/fgene.2019.00552/full
3/ A few notable changes:
a. New genomic tests, including exomes/genomes, with increased complexity of information
b. Ordering of genomic tests by colleagues in other specialties
c. More testing overall
d. Clinical genetics expanding into common diseases/population health
a. New genomic tests, including exomes/genomes, with increased complexity of information
b. Ordering of genomic tests by colleagues in other specialties
c. More testing overall
d. Clinical genetics expanding into common diseases/population health
4/ Our old clinical genetics service model, with lengthy in-person family interactions with consultant geneticists and genetic counsellors, is a privileged service model that has no hope of surviving.
We can't hire enough people to meet contemporary demands using this old model.
We can't hire enough people to meet contemporary demands using this old model.
5/ The study cited earlier describes 5 potential clinical genetics delivery models.
In Ireland's case, bringing the country's outstanding GP resources into the planning process early would probably be a sensible step @ICGPnews
In Ireland's case, bringing the country's outstanding GP resources into the planning process early would probably be a sensible step @ICGPnews
6/ And it goes without saying that a public, national genome project that directs carrier screening and tunes polygenic risk scores to the Irish population is a non-negotiable part of the foundation for these services.
7/ Bottom line -- Ireland's difficult can be Ireland's opportunity. In fixing the clinical genetics services, there's massive potential to innovate and future-proof these services so they can be cost-efficient and excellent, serving patients who have been neglected for too long.
*difficulty
(This is what happens when you try to get too smart with paraphrasing Daniel O'Connell)
(This is what happens when you try to get too smart with paraphrasing Daniel O'Connell)